BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, July 4, 2026
Breaking News: Science fiction realized: BCI tech is here
Breaking News: Science fiction realized: BCI tech is here
Breaking News: Science fiction realized: BCI tech is here
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
PSN-821 reduces energy intake in patients with obesity and type 2 diabetes
June 29, 2011
SK Chemicals' new 11-beta-HSD1 inhibitor SKI-2852 is active in models of diabetes
June 29, 2011
Novel AMPK activators synthesized
June 29, 2011
New beta-secretase 2 inhibitors for diabetes patented by Roche
June 29, 2011
FDA grants fast track status to SBC-102 in lysosomal acid lipase deficiency
June 28, 2011
FDA accepts Prochieve progesterone gel NDA for filing
June 28, 2011
CHMP issues negative opinion on Glybera MAA
June 28, 2011
EMA continues review of pioglitazone-based medicines
June 28, 2011
Blocking Smad1 phosphorylation may reduce diabetic nephropathy
June 28, 2011
CHMP recommends approval of linagliptin for type 2 diabetes
June 27, 2011
Previous
1
2
…
624
625
626
627
628
629
630
631
632
…
1798
1799
Next
RSS